Botulinum Toxin Has Variable Effectiveness in Patients with Scleroderma-associated Raynaud’s
News
Botulinum Toxin Type A (Btx-A) treatment for Raynaud’s phenomenon (RP) may not be effective for all patients diagnosed with scleroderma, according to researchers. The study, “The Therapeutic Efficacy of Botulinum Toxin in Treating ... Read more